We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardinal Health (CAH) Stock Drops Despite Market Gains: Important Facts to Note
Read MoreHide Full Article
Cardinal Health (CAH - Free Report) closed at $132.75 in the latest trading session, marking a -0.35% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.16% for the day. Meanwhile, the Dow gained 0.01%, and the Nasdaq, a tech-heavy index, added 0.46%.
Coming into today, shares of the prescription drug distributor had gained 4.44% in the past month. In that same time, the Medical sector lost 1.17%, while the S&P 500 lost 3.59%.
The investment community will be paying close attention to the earnings performance of Cardinal Health in its upcoming release. The company's earnings per share (EPS) are projected to be $2.15, reflecting a 3.37% increase from the same quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $55.03 billion, showing a 0.21% escalation compared to the year-ago quarter.
CAH's full-year Zacks Consensus Estimates are calling for earnings of $7.94 per share and revenue of $222.62 billion. These results would represent year-over-year changes of +5.44% and -1.92%, respectively.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Cardinal Health. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Cardinal Health is currently a Zacks Rank #2 (Buy).
Valuation is also important, so investors should note that Cardinal Health has a Forward P/E ratio of 16.77 right now. This valuation marks a discount compared to its industry's average Forward P/E of 16.91.
We can also see that CAH currently has a PEG ratio of 1.76. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Medical - Dental Supplies industry had an average PEG ratio of 1.81.
The Medical - Dental Supplies industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 78, which puts it in the top 32% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cardinal Health (CAH) Stock Drops Despite Market Gains: Important Facts to Note
Cardinal Health (CAH - Free Report) closed at $132.75 in the latest trading session, marking a -0.35% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.16% for the day. Meanwhile, the Dow gained 0.01%, and the Nasdaq, a tech-heavy index, added 0.46%.
Coming into today, shares of the prescription drug distributor had gained 4.44% in the past month. In that same time, the Medical sector lost 1.17%, while the S&P 500 lost 3.59%.
The investment community will be paying close attention to the earnings performance of Cardinal Health in its upcoming release. The company's earnings per share (EPS) are projected to be $2.15, reflecting a 3.37% increase from the same quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $55.03 billion, showing a 0.21% escalation compared to the year-ago quarter.
CAH's full-year Zacks Consensus Estimates are calling for earnings of $7.94 per share and revenue of $222.62 billion. These results would represent year-over-year changes of +5.44% and -1.92%, respectively.
Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Cardinal Health. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Cardinal Health is currently a Zacks Rank #2 (Buy).
Valuation is also important, so investors should note that Cardinal Health has a Forward P/E ratio of 16.77 right now. This valuation marks a discount compared to its industry's average Forward P/E of 16.91.
We can also see that CAH currently has a PEG ratio of 1.76. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Medical - Dental Supplies industry had an average PEG ratio of 1.81.
The Medical - Dental Supplies industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 78, which puts it in the top 32% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.